Financial Metrics

JNJ JOHNSON & JOHNSON

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-04-03	1.59	—	USD/shares	10-Q	2017-05-08
Quarterly	2016-07-03	1.43	-10.1%	USD/shares	10-Q	2017-08-03
Quarterly	2016-10-02	1.53	+7.0%	USD/shares	10-Q	2017-11-02
Quarterly	2017-04-02	1.61	+5.2%	USD/shares	10-Q	2018-05-01
Quarterly	2017-07-02	1.4	-13.0%	USD/shares	10-Q	2018-08-02
Quarterly	2017-10-01	1.37	-2.1%	USD/shares	10-Q	2018-10-31
Quarterly	2018-04-01	1.6	+16.8%	USD/shares	10-Q	2019-05-01
Quarterly	2018-07-01	1.45	-9.4%	USD/shares	10-Q	2019-07-29
Quarterly	2018-09-30	1.44	-0.7%	USD/shares	10-Q	2019-10-28
Quarterly	2019-03-31	1.39	-3.5%	USD/shares	10-Q	2020-04-29
Quarterly	2019-06-30	2.08	+49.6%	USD/shares	10-Q	2020-07-24
Quarterly	2019-09-29	0.66	-68.3%	USD/shares	10-Q	2020-10-23
Quarterly	2020-03-29	2.17	+228.8%	USD/shares	10-Q	2021-04-30
Quarterly	2020-06-28	1.36	-37.3%	USD/shares	10-Q	2021-07-29
Quarterly	2020-09-27	1.33	-2.2%	USD/shares	10-Q	2021-10-29
Quarterly	2021-04-04	2.32	+74.4%	USD/shares	10-Q	2022-04-29
Quarterly	2021-07-04	2.35	+1.3%	USD/shares	10-Q	2022-07-29
Quarterly	2021-10-03	1.37	-41.7%	USD/shares	10-Q	2022-10-27
Quarterly	2022-04-03	1.93	+40.9%	USD/shares	10-Q	2023-04-28
Quarterly	2022-07-03	1.8	-6.7%	USD/shares	10-Q	2023-07-31
Quarterly	2022-10-02	1.68	-6.7%	USD/shares	10-Q	2023-10-27
Quarterly	2023-04-02	-0.03	-101.8%	USD/shares	10-Q	2024-05-01
Quarterly	2023-07-02	1.96	+6633.3%	USD/shares	10-Q	2024-07-25
Quarterly	2023-10-01	10.21	+420.9%	USD/shares	10-Q	2024-10-23
Quarterly	2024-03-31	1.34	-86.9%	USD/shares	10-Q	2025-04-23
Quarterly	2024-06-30	1.93	+44.0%	USD/shares	10-Q	2025-07-24
Quarterly	2024-09-29	1.11	-42.5%	USD/shares	10-Q	2025-10-22
Quarterly	2025-03-30	4.54	+309.0%	USD/shares	10-Q	2025-04-23
Quarterly	2025-06-29	2.29	-49.6%	USD/shares	10-Q	2025-07-24
Quarterly	2025-09-28	2.12	-7.4%	USD/shares	10-Q	2025-10-22
Annual	2016-10-02	1.53	—	USD/shares	10-K	2018-02-21
Annual	2017-12-31	0.47	-69.3%	USD/shares	10-K	2020-02-18
Annual	2018-12-30	5.61	+1093.6%	USD/shares	10-K	2021-02-22
Annual	2019-12-29	5.63	+0.4%	USD/shares	10-K	2022-02-17
Annual	2021-01-03	5.51	-2.1%	USD/shares	10-K	2023-02-16
Annual	2022-10-02	1.68	-69.5%	USD/shares	10-K	2024-02-16
Annual	2023-12-31	13.72	+716.7%	USD/shares	10-K	2026-02-11
Annual	2024-12-29	5.79	-57.8%	USD/shares	10-K	2026-02-11
Annual	2025-12-28	11.03	+90.5%	USD/shares	10-K	2026-02-11

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-01-03	12857000000.0	—	USD	10-Q	2016-11-04
Quarterly	2016-04-03	20233000000.0	+57.4%	USD	10-Q	2016-05-10
Quarterly	2016-07-03	24535000000.0	+21.3%	USD	10-Q	2016-08-04
Quarterly	2016-10-02	23546000000.0	-4.0%	USD	10-Q	2016-11-04
Quarterly	2017-01-01	22442000000.0	-4.7%	USD	10-Q	2017-11-02
Quarterly	2017-04-02	27015000000.0	+20.4%	USD	10-Q	2017-05-08
Quarterly	2017-07-02	27363000000.0	+1.3%	USD	10-Q	2017-08-03
Quarterly	2017-10-01	26675000000.0	-2.5%	USD	10-Q	2017-11-02
Quarterly	2017-12-31	30675000000.0	+15.0%	USD	10-Q	2018-10-31
Quarterly	2018-04-01	29837000000.0	-2.7%	USD	10-Q	2018-05-01
Quarterly	2018-07-01	29405000000.0	-1.4%	USD	10-Q	2018-08-02
Quarterly	2018-09-30	29480000000.0	+0.3%	USD	10-Q	2018-10-31
Quarterly	2018-12-30	27684000000.0	-6.1%	USD	10-Q	2019-10-28
Quarterly	2019-03-31	27660000000.0	-0.1%	USD	10-Q	2019-05-01
Quarterly	2019-06-30	27699000000.0	+0.1%	USD	10-Q	2019-07-29
Quarterly	2019-09-29	26919000000.0	-2.8%	USD	10-Q	2019-10-28
Quarterly	2019-12-29	26494000000.0	-1.6%	USD	10-Q	2020-10-23
Quarterly	2020-03-29	25393000000.0	-4.2%	USD	10-Q	2020-04-29
Quarterly	2020-06-28	25062000000.0	-1.3%	USD	10-Q	2020-07-24
Quarterly	2020-09-27	32680000000.0	+30.4%	USD	10-Q	2020-10-23
Quarterly	2021-01-03	32635000000.0	-0.1%	USD	10-Q	2021-10-29
Quarterly	2021-04-04	30263000000.0	-7.3%	USD	10-Q	2021-04-30
Quarterly	2021-07-04	30310000000.0	+0.2%	USD	10-Q	2021-07-29
Quarterly	2021-10-03	30130000000.0	-0.6%	USD	10-Q	2021-10-29
Quarterly	2022-01-02	29985000000.0	-0.5%	USD	10-Q	2022-10-27
Quarterly	2022-04-03	28851000000.0	-3.8%	USD	10-Q	2022-04-29
Quarterly	2022-07-03	28292000000.0	-1.9%	USD	10-Q	2022-07-29
Quarterly	2022-10-02	27603000000.0	-2.4%	USD	10-Q	2022-10-27
Quarterly	2023-01-01	26886000000.0	-2.6%	USD	10-Q	2023-10-27
Quarterly	2023-04-02	34928000000.0	+29.9%	USD	10-Q	2023-04-28
Quarterly	2023-07-02	33901000000.0	-2.9%	USD	10-Q	2023-07-31
Quarterly	2023-10-01	26051000000.0	-23.2%	USD	10-Q	2023-10-27
Quarterly	2023-12-31	25881000000.0	-0.7%	USD	10-Q	2024-10-23
Quarterly	2024-03-31	25082000000.0	-3.1%	USD	10-Q	2024-05-01
Quarterly	2024-06-30	31636000000.0	+26.1%	USD	10-Q	2024-07-25
Quarterly	2024-09-29	31289000000.0	-1.1%	USD	10-Q	2024-10-23
Quarterly	2024-12-29	30651000000.0	-2.0%	USD	10-Q	2025-10-22
Quarterly	2025-03-30	38355000000.0	+25.1%	USD	10-Q	2025-04-23
Quarterly	2025-06-29	39235000000.0	+2.3%	USD	10-Q	2025-07-24
Quarterly	2025-09-28	39408000000.0	+0.4%	USD	10-Q	2025-10-22
Annual	2016-01-03	12857000000.0	—	USD	10-K	2017-02-27
Annual	2017-12-31	30675000000.0	+138.6%	USD	10-K	2019-02-20
Annual	2018-12-30	27684000000.0	-9.8%	USD	10-K	2020-02-18
Annual	2019-12-29	26494000000.0	-4.3%	USD	10-K	2021-02-22
Annual	2021-01-03	34434000000.0	+30.0%	USD	10-K	2022-02-17
Annual	2022-01-02	32116000000.0	-6.7%	USD	10-K	2023-02-16
Annual	2023-12-31	27350000000.0	-14.8%	USD	10-K	2025-02-13
Annual	2024-12-29	32400000000.0	+18.5%	USD	10-K	2026-02-11
Annual	2025-12-28	41438000000.0	+27.9%	USD	10-K	2026-02-11

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-04-03	639000000.0	—	USD	10-Q	2017-05-08
Quarterly	2016-07-03	1396000000.0	+118.5%	USD	10-Q	2017-08-03
Quarterly	2016-10-02	2133000000.0	+52.8%	USD	10-Q	2017-11-02
Quarterly	2017-04-02	560000000.0	-73.7%	USD	10-Q	2018-05-01
Quarterly	2017-07-02	1249000000.0	+123.0%	USD	10-Q	2018-08-02
Quarterly	2017-10-01	2039000000.0	+63.3%	USD	10-Q	2018-10-31
Quarterly	2018-04-01	658000000.0	-67.7%	USD	10-Q	2019-05-01
Quarterly	2018-07-01	1533000000.0	+133.0%	USD	10-Q	2019-07-29
Quarterly	2018-09-30	2352000000.0	+53.4%	USD	10-Q	2019-10-28
Quarterly	2019-03-31	656000000.0	-72.1%	USD	10-Q	2020-04-29
Quarterly	2019-06-30	1493000000.0	+127.6%	USD	10-Q	2020-07-24
Quarterly	2019-09-29	2238000000.0	+49.9%	USD	10-Q	2020-10-23
Quarterly	2020-03-29	625000000.0	-72.1%	USD	10-Q	2021-04-30
Quarterly	2020-06-28	1287000000.0	+105.9%	USD	10-Q	2021-07-29
Quarterly	2020-09-27	2024000000.0	+57.3%	USD	10-Q	2021-10-29
Quarterly	2021-04-04	677000000.0	-66.6%	USD	10-Q	2022-04-29
Quarterly	2021-07-04	1490000000.0	+120.1%	USD	10-Q	2022-07-29
Quarterly	2021-10-03	2237000000.0	+50.1%	USD	10-Q	2022-10-27
Quarterly	2022-04-03	607000000.0	-72.9%	USD	10-Q	2023-04-28
Quarterly	2022-07-03	1470000000.0	+142.2%	USD	10-Q	2023-07-31
Quarterly	2022-10-02	2422000000.0	+64.8%	USD	10-Q	2023-10-27
Quarterly	2023-04-02	863000000.0	-64.4%	USD	10-Q	2024-05-01
Quarterly	2023-07-02	1987000000.0	+130.2%	USD	10-Q	2024-07-25
Quarterly	2023-10-01	2954000000.0	+48.7%	USD	10-Q	2024-10-23
Quarterly	2024-03-31	807000000.0	-72.7%	USD	10-Q	2025-04-23
Quarterly	2024-06-30	1783000000.0	+120.9%	USD	10-Q	2025-07-24
Quarterly	2024-09-29	2812000000.0	+57.7%	USD	10-Q	2025-10-22
Quarterly	2025-03-30	795000000.0	-71.7%	USD	10-Q	2025-04-23
Quarterly	2025-06-29	1838000000.0	+131.2%	USD	10-Q	2025-07-24
Quarterly	2025-09-28	2995000000.0	+62.9%	USD	10-Q	2025-10-22
Annual	2016-01-03	3463000000.0	—	USD	10-K	2018-02-21
Annual	2017-12-31	3279000000.0	-5.3%	USD	10-K	2020-02-18
Annual	2018-12-30	3670000000.0	+11.9%	USD	10-K	2021-02-22
Annual	2019-12-29	3498000000.0	-4.7%	USD	10-K	2022-02-17
Annual	2021-01-03	3347000000.0	-4.3%	USD	10-K	2023-02-16
Annual	2022-01-02	3652000000.0	+9.1%	USD	10-K	2024-02-16
Annual	2023-12-31	4543000000.0	+24.4%	USD	10-K	2026-02-11
Annual	2024-12-29	4424000000.0	-2.6%	USD	10-K	2026-02-11
Annual	2025-12-28	4832000000.0	+9.2%	USD	10-K	2026-02-11

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-04-03	2803800000.0	—	shares	10-Q	2017-05-08
Quarterly	2016-07-03	2794200000.0	-0.3%	shares	10-Q	2017-08-03
Quarterly	2016-10-02	2785400000.0	-0.3%	shares	10-Q	2017-11-02
Quarterly	2017-04-02	2754500000.0	-1.1%	shares	10-Q	2018-05-01
Quarterly	2017-07-02	2741500000.0	-0.5%	shares	10-Q	2018-08-02
Quarterly	2017-10-01	2737700000.0	-0.1%	shares	10-Q	2018-10-31
Quarterly	2018-04-01	2731900000.0	-0.2%	shares	10-Q	2019-05-01
Quarterly	2018-07-01	2721300000.0	-0.4%	shares	10-Q	2019-07-29
Quarterly	2018-09-30	2727600000.0	+0.2%	shares	10-Q	2019-10-28
Quarterly	2019-03-31	2698800000.0	-1.1%	shares	10-Q	2020-04-29
Quarterly	2019-06-30	2691700000.0	-0.3%	shares	10-Q	2020-07-24
Quarterly	2019-09-29	2669900000.0	-0.8%	shares	10-Q	2020-10-23
Quarterly	2020-03-29	2671000000.0	+0.0%	shares	10-Q	2021-04-30
Quarterly	2020-06-28	2665500000.0	-0.2%	shares	10-Q	2021-07-29
Quarterly	2020-09-27	2669300000.0	+0.1%	shares	10-Q	2021-10-29
Quarterly	2021-04-04	2672700000.0	+0.1%	shares	10-Q	2022-04-29
Quarterly	2021-07-04	2671600000.0	-0.0%	shares	10-Q	2022-07-29
Quarterly	2021-10-03	2674900000.0	+0.1%	shares	10-Q	2022-10-27
Quarterly	2022-04-03	2666500000.0	-0.3%	shares	10-Q	2023-04-28
Quarterly	2022-07-03	2667900000.0	+0.1%	shares	10-Q	2023-07-31
Quarterly	2022-10-02	2661300000.0	-0.2%	shares	10-Q	2023-10-27
Quarterly	2023-04-02	2605500000.0	-2.1%	shares	10-Q	2024-05-01
Quarterly	2023-07-02	2625700000.0	+0.8%	shares	10-Q	2024-07-25
Quarterly	2023-10-01	2549700000.0	-2.9%	shares	10-Q	2024-10-23
Quarterly	2024-03-31	2430100000.0	-4.7%	shares	10-Q	2025-04-23
Quarterly	2024-06-30	2422000000.0	-0.3%	shares	10-Q	2025-07-24
Quarterly	2024-09-29	2427900000.0	+0.2%	shares	10-Q	2025-10-22
Quarterly	2025-03-30	2423800000.0	-0.2%	shares	10-Q	2025-04-23
Quarterly	2025-06-29	2419100000.0	-0.2%	shares	10-Q	2025-07-24
Quarterly	2025-09-28	2428600000.0	+0.4%	shares	10-Q	2025-10-22
Annual	2016-01-03	2812900000.0	—	shares	10-K	2018-02-21
Annual	2017-12-31	2745300000.0	-2.4%	shares	10-K	2020-02-18
Annual	2018-12-30	2728700000.0	-0.6%	shares	10-K	2021-02-22
Annual	2019-12-29	2684300000.0	-1.6%	shares	10-K	2022-02-17
Annual	2021-01-03	2670700000.0	-0.5%	shares	10-K	2023-02-16
Annual	2022-01-02	2674000000.0	+0.1%	shares	10-K	2024-02-16
Annual	2023-12-31	2560400000.0	-4.2%	shares	10-K	2026-02-11
Annual	2024-12-29	2429400000.0	-5.1%	shares	10-K	2026-02-11
Annual	2025-12-28	2429400000.0	+0.0%	shares	10-K	2026-02-11

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

41,438,000,000

Total Liabilities (latest annual)

117,666,000,000

Current Liabilities (latest annual)

54,126,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-04-03	0.0614	—	ratio	10-Q	2017-05-08
Quarterly	2016-07-03	0.0552	-10.1%	ratio	10-Q	2017-08-03
Quarterly	2016-10-02	0.0587	+6.4%	ratio	10-Q	2017-11-02
Quarterly	2017-04-02	0.0629	+7.1%	ratio	10-Q	2018-05-01
Quarterly	2017-07-02	0.0532	-15.4%	ratio	10-Q	2018-08-02
Quarterly	2017-10-01	0.0509	-4.4%	ratio	10-Q	2018-10-31
Quarterly	2018-04-01	0.0690	+35.7%	ratio	10-Q	2019-05-01
Quarterly	2018-07-01	0.0629	-8.9%	ratio	10-Q	2019-07-29
Quarterly	2018-09-30	0.0609	-3.2%	ratio	10-Q	2019-10-28
Quarterly	2019-03-31	0.0636	+4.5%	ratio	10-Q	2020-04-29
Quarterly	2019-06-30	0.0922	+45.1%	ratio	10-Q	2020-07-24
Quarterly	2019-09-29	0.0301	-67.4%	ratio	10-Q	2020-10-23
Quarterly	2020-03-29	0.0946	+214.0%	ratio	10-Q	2021-04-30
Quarterly	2020-06-28	0.0576	-39.1%	ratio	10-Q	2021-07-29
Quarterly	2020-09-27	0.0551	-4.3%	ratio	10-Q	2021-10-29
Quarterly	2021-04-04	0.0941	+70.8%	ratio	10-Q	2022-04-29
Quarterly	2021-07-04	0.0902	-4.1%	ratio	10-Q	2022-07-29
Quarterly	2021-10-03	0.0522	-42.2%	ratio	10-Q	2022-10-27
Quarterly	2022-04-03	0.0689	+32.1%	ratio	10-Q	2023-04-28
Quarterly	2022-07-03	0.0630	-8.5%	ratio	10-Q	2023-07-31
Quarterly	2022-10-02	0.0598	-5.2%	ratio	10-Q	2023-10-27
Quarterly	2023-04-02	-0.0010	-101.6%	ratio	10-Q	2024-05-01
Quarterly	2023-07-02	0.0673	+7116.2%	ratio	10-Q	2024-07-25
Quarterly	2023-10-01	0.3654	+442.8%	ratio	10-Q	2024-10-23
Quarterly	2024-03-31	0.0465	-87.3%	ratio	10-Q	2025-04-23
Quarterly	2024-06-30	0.0655	+40.9%	ratio	10-Q	2025-07-24
Quarterly	2024-09-29	0.0384	-41.4%	ratio	10-Q	2025-10-22
Quarterly	2025-03-30	0.1408	+266.7%	ratio	10-Q	2025-04-23
Quarterly	2025-06-29	0.0706	-49.9%	ratio	10-Q	2025-07-24
Quarterly	2025-09-28	0.0650	-7.9%	ratio	10-Q	2025-10-22
Annual	2017-12-31	0.0216	—	ratio	10-K	2020-02-18
Annual	2018-12-30	0.2560	+1084.7%	ratio	10-K	2021-02-22
Annual	2019-12-29	0.2542	-0.7%	ratio	10-K	2022-02-17
Annual	2021-01-03	0.2325	-8.5%	ratio	10-K	2023-02-16
Annual	2023-12-31	0.5111	+119.8%	ratio	10-K	2026-02-11
Annual	2024-12-29	0.1968	-61.5%	ratio	10-K	2026-02-11
Annual	2025-12-28	0.3287	+67.1%	ratio	10-K	2026-02-11

8-K Material Event Details

63 filings · 114 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

449 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-10	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	206	$242.14	$50,000	14,513
2026-03-10	Pinto Daniel E	Dir	Equity grant / award A · derivative	Deferred Share Units	129	$242.14	$31,250	462
2026-02-27	Decker Robert J	VP Corporate Controller	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	4,075	$0.00	$0	0
2026-02-27	Decker Robert J	VP Corporate Controller	Open-market sell S	Common Stock	4,075	$247.87	$1,010,070	23,682
2026-02-27	Decker Robert J	VP Corporate Controller	Exercise / conversion M	Common Stock	4,075	$115.67	$471,355	27,757
2026-02-20	Schmid Timothy	EVP, WW Chair, MedTech	Open-market sell S	Common Stock	1,322	$245.66	$324,763	25,447
2026-02-17	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	20,521	$0.00	$0	0
2026-02-17	Swanson James D.	EVP, CIO	Open-market sell S	Common Stock	20,521	$242.70	$4,980,447	25,698
2026-02-17	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	20,521	$164.62	$3,378,167	46,219
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	29,927	$0.00	$0	59,854
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	21,721	$0.00	$0	21,721
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Open-market sell S	Common Stock	2,283	$243.00	$554,769	10,658
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Open-market sell S	Common Stock	29,927	$243.00	$7,272,261	12,941
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	29,927	$156.15	$4,673,101	42,868
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Open-market sell S	Common Stock	21,721	$243.00	$5,278,203	12,941
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	21,721	$157.92	$3,430,180	34,662
2026-02-15	Swanson James D.	EVP, CIO	Equity grant / award A · derivative	Restricted Share Units	1,397	$0.00	$0	1,397
2026-02-15	Swanson James D.	EVP, CIO	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	19,449	$0.00	$0	19,449
2026-02-15	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Restricted Share Units	709	$0.00	$0	1,418
2026-02-15	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Restricted Share Units	492	$0.00	$0	491
2026-02-15	Swanson James D.	EVP, CIO	Other disposed transaction F	Common Stock	309	$243.45	$75,226	25,698
2026-02-15	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	709	$0.00	$0	26,007
2026-02-15	Swanson James D.	EVP, CIO	Other disposed transaction F	Common Stock	214	$243.45	$52,098	25,298
2026-02-15	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	492	$0.00	$0	25,512
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Equity grant / award A · derivative	Restricted Share Units	3,546	$0.00	$0	3,546
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	49,382	$0.00	$0	49,382
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Restricted Share Units	1,847	$0.00	$0	3,692
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Restricted Share Units	1,349	$0.00	$0	1,349
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Other disposed transaction F	Common Stock	528	$243.45	$128,542	12,941
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	1,847	$0.00	$0	13,469
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Other disposed transaction F	Common Stock	385	$243.45	$93,728	11,622
2026-02-15	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	1,349	$0.00	$0	12,007
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	22,191	$0.00	$0	0
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	19,368	$0.00	$0	0
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Performance Share Units	9,412	$0.00	$0	0
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M · derivative	Restricted Share Units	447	$0.00	$0	0
2026-02-13	Swanson James D.	EVP, CIO	Open-market sell S	Common Stock	22,191	$243.71	$5,408,169	25,020
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	22,191	$162.75	$3,611,585	47,211
2026-02-13	Swanson James D.	EVP, CIO	Open-market sell S	Common Stock	19,368	$243.76	$4,721,144	25,020
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	19,368	$165.89	$3,212,958	44,388
2026-02-13	Swanson James D.	EVP, CIO	Other disposed transaction F	Common Stock	3,547	$244.55	$867,419	25,020
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	9,412	$0.00	$0	28,567
2026-02-13	Swanson James D.	EVP, CIO	Other disposed transaction F	Common Stock	143	$244.55	$34,971	19,155
2026-02-13	Swanson James D.	EVP, CIO	Exercise / conversion M	Common Stock	447	$0.00	$0	19,298
2026-02-09	Wolk Joseph J	Exec VP, CFO	Equity grant / award A · derivative	Performance Share Units	37,463	$0.00	$0	37,463
2026-02-06	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	15,571	$101.87	$1,586,218	0
2026-02-06	Schmid Timothy	EVP, WW Chair, MedTech	Other disposed transaction F	Common Stock	10,335	$239.99	$2,480,297	22,125
2026-02-06	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	15,571	$101.87	$1,586,218	32,460
2026-02-05	Forminard Elizabeth	EVP, Chief Legal Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	8,921	$129.51	$1,155,359	0
2026-02-05	Forminard Elizabeth	EVP, Chief Legal Officer	Other disposed transaction F	Common Stock	6,226	$237.90	$1,481,165	15,548
2026-02-05	Forminard Elizabeth	EVP, Chief Legal Officer	Exercise / conversion M	Common Stock	8,921	$129.51	$1,155,359	21,774
2026-01-26	Duato Joaquin	CEO and Chairman of the Board	Open-market sell S	Common Stock	48,782	$221.48	$10,804,432	30,852
2026-01-26	Duato Joaquin	CEO and Chairman of the Board	Open-market sell S	Common Stock	51,218	$220.99	$11,318,461	79,634
2025-12-09	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	186	$202.12	$37,500	5,058
2025-11-26	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	6,337	$10.03	$63,560	4,024,861
2025-11-26	MORIKIS JOHN G	Dir	Open-market buy P	Common Stock	1,250	$206.15	$257,688	1,849
2025-11-25	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	16,000	$10.03	$160,480	4,031,198
2025-11-24	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	2,200	$10.06	$22,132	4,047,198
2025-11-21	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	500	$10.00	$5,000	4,049,398
2025-11-12	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	1,000	$10.00	$10,000	4,049,898
2025-11-07	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	200	$10.00	$2,000	4,050,898
2025-11-06	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	52,332	$10.21	$534,310	4,051,098
2025-10-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	21,721	$157.92	$3,430,180	43,442
2025-10-17	REED JOHN C	EVP, Innovative Medicine, R&D	Open-market sell S	Common Stock	21,721	$192.71	$4,185,793	10,658
2025-10-17	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	21,721	$157.92	$3,430,180	32,379
2025-09-09	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	281	$178.07	$50,000	13,817
2025-09-04	Taubert Jennifer L	EVP, WWC. Innovative Medicine	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	56,471	$101.87	$5,752,701	0
2025-09-04	Taubert Jennifer L	EVP, WWC. Innovative Medicine	Open-market sell S	Common Stock	56,471	$177.81	$10,040,883	178,013
2025-09-04	Taubert Jennifer L	EVP, WWC. Innovative Medicine	Exercise / conversion M	Common Stock	56,471	$101.87	$5,752,701	234,484
2025-08-29	Forminard Elizabeth	Executive VP, General Counsel	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	11,521	$115.67	$1,332,634	0
2025-08-29	Forminard Elizabeth	Executive VP, General Counsel	Other disposed transaction F	Common Stock	9,570	$177.20	$1,695,804	12,853
2025-08-29	Forminard Elizabeth	Executive VP, General Counsel	Exercise / conversion M	Common Stock	11,521	$115.67	$1,332,634	22,423
2025-08-22	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	125,824	$101.87	$12,817,691	0
2025-08-22	Duato Joaquin	CEO and Chairman of the Board	Open-market sell S	Common Stock	125,824	$179.21	$22,548,655	275,967
2025-08-22	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M	Common Stock	125,824	$101.87	$12,817,691	401,791
2025-08-15	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	16,820	$101.87	$1,713,453	0
2025-08-15	Wolk Joseph J	Exec VP, CFO	Open-market sell S	Common Stock	16,820	$176.91	$2,975,571	14,000
2025-08-15	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M	Common Stock	16,820	$101.87	$1,713,453	30,820
2025-07-17	REED JOHN C	EVP, Innovative Medicine, R&D	Open-market sell S	Common Stock	19,137	$163.55	$3,129,830	10,658
2025-06-10	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	322	$155.23	$50,000	13,438
2025-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Restricted Share Units	25,255	$0.00	$0	25,255
2025-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Other disposed transaction F	Common Stock	11,002	$156.31	$1,719,723	29,795
2025-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	25,255	$0.00	$0	40,797
2025-04-24	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	1,316	$0.00	$0	4,330
2025-03-18	Duato Joaquin	CEO and Chairman of the Board	Equity grant / award G	Common Stock	130,852	$0.00	$0	130,852
2025-03-04	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	75	$166.10	$12,500	14,306
2025-02-25	Decker Robert J	VP Corporate Controller	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	6,999	$101.87	$712,988	0
2025-02-25	Decker Robert J	VP Corporate Controller	Open-market sell S	Common Stock	6,999	$165.88	$1,160,994	21,001
2025-02-25	Decker Robert J	VP Corporate Controller	Exercise / conversion M	Common Stock	6,999	$101.87	$712,988	28,000
2025-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Open-market sell S	Common Stock	403	$156.15	$62,928	15,098
2025-02-15	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Restricted Share Units	1,029	$0.00	$0	2,056
2025-02-15	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	1,029	$0.00	$0	15,501
2025-02-15	Wolk Joseph J	Exec VP, CFO	Equity grant / award A · derivative	Restricted Share Units	5,632	$0.00	$0	5,632
2025-02-15	Wolk Joseph J	Exec VP, CFO	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	91,277	$0.00	$0	91,277
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Restricted Share Units	1,765	$0.00	$0	0
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Other disposed transaction F	Common Stock	639	$156.71	$100,138	14,472
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	1,765	$0.00	$0	15,111
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Other disposed transaction F	Common Stock	193	$155.26	$29,965	13,346
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Performance Share Units	2,806	$0.00	$0	0
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Other disposed transaction F	Common Stock	1,015	$156.71	$159,061	16,889
2025-02-14	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	2,806	$0.00	$0	17,904
2025-02-13	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Restricted Share Units	499	$0.00	$0	499
2025-02-13	Schmid Timothy	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	499	$0.00	$0	13,539
2025-02-10	Decker Robert J	VP Corporate Controller	Equity grant / award A · derivative	Performance Share Units	1,351	$0.00	$0	1,351
2025-02-07	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	126,369	$100.06	$12,644,482	0
2025-02-07	Duato Joaquin	CEO and Chairman of the Board	Other disposed transaction F	Common Stock	100,643	$153.12	$15,410,456	389,028
2025-02-07	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M	Common Stock	126,369	$100.06	$12,644,482	489,671
2024-12-12	WEINBERGER MARK A	Dir	Open-market buy P	Common Stock	1,000	$147.22	$147,220	1,000
2024-12-10	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	209	$149.67	$31,250	2,805
2024-10-17	Wolk Joseph J	Exec VP, CFO	Equity grant / award G	Common Stock	68,835	$0.00	$0	68,835
2024-09-10	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	188	$165.94	$31,250	2,574
2024-08-30	Decker Robert J	VP Corporate Controller	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	5,635	$0.00	$0	0
2024-08-30	Decker Robert J	VP Corporate Controller	Open-market sell S	Common Stock	5,635	$165.06	$930,113	18,973
2024-08-30	Decker Robert J	VP Corporate Controller	Exercise / conversion M	Common Stock	5,635	$100.06	$563,838	24,608
2024-07-08	Broadhurst Vanessa	EVP, Global Corp Affairs	Exercise / conversion M · derivative	Restricted Share Units	9,809	$0.00	$0	0
2024-07-08	Broadhurst Vanessa	EVP, Global Corp Affairs	Other disposed transaction F	Common Stock	5,018	$147.16	$738,449	19,834
2024-07-08	Broadhurst Vanessa	EVP, Global Corp Affairs	Exercise / conversion M	Common Stock	9,809	$0.00	$0	24,852
2024-06-04	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	211	$147.85	$31,250	2,368
2024-05-22	Wolk Joseph J	Exec VP, CFO	Equity grant / award G	Common Stock	55	$0.00	$0	68,835
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Restricted Share Units	22,255	$0.00	$0	53,510
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Other disposed transaction F	Common Stock	10,984	$144.59	$1,588,177	11,577
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	22,255	$0.00	$0	22,561
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M · derivative	Restricted Share Units	25,255	$0.00	$0	50,510
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Other disposed transaction F	Common Stock	10,984	$144.59	$1,588,177	14,577
2024-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Exercise / conversion M	Common Stock	25,255	$0.00	$0	25,561
2024-04-25	DAVIS D SCOTT	Dir	Equity grant / award A · derivative	Deferred Share Units	1,386	$0.00	$0	15,604
2024-03-13	Broadhurst Vanessa	EVP, Global Corp Affairs	Open-market sell S	Common Stock	8,891	$162.16	$1,441,765	15,043
2024-03-05	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	262	$159.80	$41,866	753
2024-03-05	Woods Eugene A.	Dir	Equity grant / award A · derivative	Deferred Share Units	491	$159.80	$78,534	491
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	79	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	252	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	142	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	442	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	300	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	584	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	489	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	758	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	85	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	23	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	71	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	118	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	165	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	189	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M · derivative	Stock Option (Right to Buy)	158	$0.00	$0	0
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	79	$5.14	$406	4,103,430
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	252	$3.96	$997	4,103,351
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	142	$1.19	$168	4,103,099
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	442	$1.19	$524	4,102,957
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	300	$0.24	$71	4,102,515
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	584	$0.24	$138	4,102,215
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	489	$0.24	$116	4,101,631
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	758	$0.24	$180	4,101,142
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	85	$0.24	$20	4,100,384
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	23	$0.24	$5	4,100,299
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	71	$0.24	$17	4,100,276
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	118	$0.24	$28	4,100,205
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	165	$0.24	$39	4,100,087
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	189	$0.24	$45	4,099,922
2024-02-29	JOHNSON & JOHNSON	—	Exercise / conversion M	Common Stock	158	$0.24	$37	4,099,733
2024-02-16	JOHNSON & JOHNSON	—	Exercise / conversion X · derivative	Warrant to Purchase Common Stock	607,225	$0.00	$0	0
2024-02-16	JOHNSON & JOHNSON	—	Open-market sell S	Common Stock	3,725	$25.81	$96,142	4,099,575
2024-02-16	JOHNSON & JOHNSON	—	Exercise / conversion X	Common Stock	607,725	$0.16	$96,021	4,103,300
2024-02-15	Taubert Jennifer L	EVP, WWC. Innovative Medicine	Equity grant / award A · derivative	Restricted Share Units	4,782	$0.00	$0	4,782
2024-02-15	Taubert Jennifer L	EVP, WWC. Innovative Medicine	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	76,981	$0.00	$0	76,981
2024-02-13	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Exercise / conversion M · derivative	Restricted Share Units	651	$0.00	$0	1,302
2024-02-13	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Other disposed transaction F	Common Stock	333	$157.85	$52,564	82,266
2024-02-13	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Exercise / conversion M	Common Stock	651	$0.00	$0	82,599
2024-02-12	Broadhurst Vanessa	EVP, Global Corp Affairs	Exercise / conversion M · derivative	Performance Share Units	4,701	$0.00	$0	0
2024-02-12	Broadhurst Vanessa	EVP, Global Corp Affairs	Other disposed transaction F	Common Stock	2,136	$157.40	$336,206	23,735
2024-02-12	Broadhurst Vanessa	EVP, Global Corp Affairs	Equity grant / award A	Common Stock	790	$0.00	$0	25,871
2024-02-12	Broadhurst Vanessa	EVP, Global Corp Affairs	Exercise / conversion M	Common Stock	4,701	$0.00	$0	25,081
2024-02-09	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	59,397	$0.00	$0	0
2024-02-09	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Open-market sell S	Common Stock	59,397	$156.27	$9,281,969	141,416
2024-02-09	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M	Common Stock	59,397	$90.44	$5,371,865	200,813
2024-02-09	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	35,638	$90.44	$3,223,101	0
2024-02-09	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Other disposed transaction F	Common Stock	27,333	$156.76	$4,284,721	75,201
2024-02-09	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Exercise / conversion M	Common Stock	35,638	$90.44	$3,223,101	102,534
2024-02-08	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M · derivative	Restricted Share Units	3,739	$0.00	$0	0
2024-02-08	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Other disposed transaction F	Common Stock	1,913	$156.33	$299,059	141,416
2024-02-08	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M	Common Stock	3,739	$0.00	$0	143,329
2023-12-05	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	228	$159.01	$36,250	8,490
2023-09-07	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	229	$158.63	$36,250	8,201
2023-08-23	JOHNSON & JOHNSON	10%	Other disposed transaction J	Common Stock	1,533,830,450	—	—	182,329,550
2023-07-26	Hait William	See Remarks	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	14,698	$0.00	$0	0
2023-07-26	Hait William	See Remarks	Open-market sell S	Common Stock	14,698	$172.00	$2,528,056	87,747
2023-07-26	Hait William	See Remarks	Exercise / conversion M	Common Stock	14,698	$90.44	$1,329,287	102,445
2023-07-25	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	20,000	$170.32	$3,406,498	102,696
2023-06-12	Wengel Kathryn E	EVP, Chief TO and Risk Officer	Open-market sell S	Common Stock	12,465	$160.00	$1,994,400	65,934
2023-06-06	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	230	$157.52	$36,250	7,913
2023-05-24	Wolk Joseph J	Exec VP, CFO	Equity grant / award G	Common Stock	55	$0.00	$0	50,342
2023-05-01	REED JOHN C	EVP, Pharmaceuticals R&D	Equity grant / award A · derivative	Restricted Share Units	75,765	$0.00	$0	75,765
2023-04-27	West Nadja	Dir	Equity grant / award A · derivative	Deferred Share Units	1,194	$0.00	$0	3,599
2023-03-07	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	201	$155.16	$31,250	28,569
2023-03-06	Swanson James D.	See Remarks	Open-market sell S	Common Stock	1,062	$154.66	$164,199	9,215
2023-02-13	Wolk Joseph J	Exec VP, CFO	Equity grant / award A · derivative	Restricted Share Units	5,338	$0.00	$0	5,338
2023-02-13	Wolk Joseph J	Exec VP, CFO	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	88,334	$0.00	$0	88,334
2023-02-13	Wolk Joseph J	Exec VP, CFO	Other disposed transaction F	Common Stock	8,578	$162.01	$1,389,722	50,397
2023-02-13	Wolk Joseph J	Exec VP, CFO	Equity grant / award A	Common Stock	20,693	$0.00	$0	58,975
2023-02-10	Swanson James D.	See Remarks	Exercise / conversion M · derivative	Restricted Share Units	1,291	$0.00	$0	0
2023-02-10	Swanson James D.	See Remarks	Other disposed transaction F	Common Stock	388	$162.08	$62,887	7,967
2023-02-10	Swanson James D.	See Remarks	Exercise / conversion M	Common Stock	1,291	$0.00	$0	8,355
2023-02-10	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M · derivative	Restricted Share Units	5,220	$0.00	$0	0
2023-02-10	Duato Joaquin	CEO and Chairman of the Board	Other disposed transaction F	Common Stock	2,267	$162.08	$367,435	298,673
2023-02-10	Duato Joaquin	CEO and Chairman of the Board	Exercise / conversion M	Common Stock	5,220	$0.00	$0	300,940
2023-01-17	Gorsky Alex	Dir	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	547,692	$72.54	$39,729,578	0
2023-01-17	Gorsky Alex	Dir	Other disposed transaction F	Common Stock	366,610	$173.43	$63,581,172	766,584
2023-01-17	Gorsky Alex	Dir	Exercise / conversion M	Common Stock	547,692	$72.54	$39,729,578	1,133,194
2022-12-13	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	12,926	$0.00	$0	0
2022-12-13	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	1,855	$0.00	$0	0
2022-12-13	Wolk Joseph J	Exec VP, CFO	Open-market sell S	Common Stock	12,926	$179.62	$2,321,755	35,812
2022-12-13	Wolk Joseph J	Exec VP, CFO	Open-market sell S	Common Stock	1,855	$179.46	$332,906	48,738
2022-12-13	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M	Common Stock	1,855	$72.54	$134,562	50,593
2022-12-13	Wolk Joseph J	Exec VP, CFO	Exercise / conversion M	Common Stock	12,926	$90.44	$1,169,027	48,738
2022-12-06	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	241	$178.70	$43,070	6,276
2022-11-30	McEvoy Ashley	EVP, WW Chair, MedTech	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	73,323	$0.00	$0	0
2022-11-30	McEvoy Ashley	EVP, WW Chair, MedTech	Open-market sell S	Common Stock	71,923	$175.46	$12,619,272	41,813
2022-11-30	McEvoy Ashley	EVP, WW Chair, MedTech	Open-market sell S	Common Stock	1,400	$176.09	$246,529	113,736
2022-11-30	McEvoy Ashley	EVP, WW Chair, MedTech	Exercise / conversion M	Common Stock	73,323	$72.54	$5,318,850	115,136
2022-11-22	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	76,923	$0.00	$0	0
2022-11-22	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Open-market sell S	Common Stock	76,923	$176.78	$13,598,402	126,456
2022-11-22	Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Exercise / conversion M	Common Stock	76,923	$72.54	$5,579,994	203,379
2022-11-18	Decker Robert J	Controller, CAO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	16,928	$0.00	$0	0
2022-11-18	Decker Robert J	Controller, CAO	Open-market sell S	Common Stock	16,928	$175.00	$2,962,400	15,473
2022-11-18	Decker Robert J	Controller, CAO	Exercise / conversion M	Common Stock	16,928	$90.44	$1,530,968	32,401
2022-11-09	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	16,410	$0.00	$0	0
2022-11-09	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	16,410	$173.42	$2,845,773	71,311
2022-11-09	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	16,410	$72.54	$1,190,381	87,721
2022-11-07	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	10,033	$115.67	$1,160,517	0
2022-11-07	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	7,010	$101.87	$714,109	0
2022-11-07	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	7,010	$101.87	$714,109	57,176
2022-11-07	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	10,033	$115.67	$1,160,517	50,166
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	16,953	$0.00	$0	0
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	18,293	$0.00	$0	0
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	18,293	$171.22	$3,132,036	40,133
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	16,953	$171.14	$2,901,269	58,426
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	16,953	$129.51	$2,195,583	75,379
2022-11-04	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	18,293	$131.94	$2,413,578	58,426
2022-11-02	Swanson James D.	EVP, Chief Information Officer	Exercise / conversion M · derivative	Restricted Share Units	9,912	$0.00	$0	0
2022-11-02	Swanson James D.	EVP, Chief Information Officer	Other disposed transaction F	Common Stock	3,932	$172.29	$677,444	7,064
2022-11-02	Swanson James D.	EVP, Chief Information Officer	Exercise / conversion M	Common Stock	9,912	$0.00	$0	10,996
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,912	$171.36	$327,644	114,676
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,780	$171.36	$305,024	116,588
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,757	$171.36	$301,083	118,368
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,540	$171.36	$263,897	120,125
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,499	$171.36	$256,872	121,665
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,462	$171.36	$250,531	123,164
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,390	$171.36	$238,193	124,626
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,271	$171.36	$217,801	126,016
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,180	$171.36	$202,207	127,287
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,159	$171.36	$198,609	128,467
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,100	$171.36	$188,498	129,626
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,088	$171.36	$186,442	130,726
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,073	$171.36	$183,871	131,814
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,000	$171.36	$171,362	132,887
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	963	$171.36	$165,022	134,887
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	943	$171.36	$161,594	135,850
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	927	$171.36	$158,853	136,793
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	901	$171.36	$154,397	137,720
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	900	$171.36	$154,226	140,421
2022-10-24	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	830	$171.36	$142,230	143,121
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	2,231	$164.50	$367,006	114,676
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,926	$164.50	$316,833	116,907
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,891	$164.50	$311,075	118,833
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,887	$164.50	$310,417	120,724
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,878	$164.50	$308,937	122,611
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,668	$164.50	$274,391	124,489
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,633	$164.50	$268,633	126,157
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,480	$164.50	$243,464	127,790
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,415	$164.50	$232,772	129,270
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,401	$164.50	$230,469	130,685
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,400	$164.50	$230,304	132,086
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,354	$164.50	$222,737	134,886
2022-10-19	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	1,300	$164.50	$213,854	138,840
2022-09-06	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	261	$164.11	$42,775	6,035
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	40,000	$0.00	$0	16,410
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	33,126	$173.00	$5,730,831	71,311
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	6,600	$173.00	$1,141,807	104,437
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	174	$173.00	$30,102	111,037
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	100	$173.00	$17,300	111,211
2022-06-10	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	40,000	$72.54	$2,901,600	111,311
2022-06-07	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	240	$177.25	$42,504	5,774
2022-05-26	Decker Robert J	Controller, CAO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	8,462	$0.00	$0	0
2022-05-26	Decker Robert J	Controller, CAO	Open-market sell S	Common Stock	8,462	$180.00	$1,523,160	15,473
2022-05-26	Decker Robert J	Controller, CAO	Exercise / conversion M	Common Stock	8,462	$72.54	$613,833	23,935
2022-04-21	Hait William	See Remarks	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	29,699	$0.00	$0	29,698
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	22,591	$183.58	$4,147,188	80,236
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	2,884	$183.58	$529,436	102,827
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	1,696	$183.58	$311,347	105,711
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	1,403	$183.58	$257,559	107,407
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	700	$183.58	$128,504	108,810
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	225	$183.58	$41,305	109,510
2022-04-21	Hait William	See Remarks	Open-market sell S	Common Stock	100	$183.58	$18,358	109,735
2022-04-21	Hait William	See Remarks	Exercise / conversion M	Common Stock	29,699	$90.44	$2,685,978	109,935
2022-04-20	Wolk Joseph J	Exec VP, CFO	Equity grant / award G	Common Stock	28	$0.00	$0	35,812
2022-04-20	Wolk Joseph J	Exec VP, CFO	Equity grant / award G	Common Stock	18	$0.00	$0	35,840
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	6,566	$176.24	$1,157,179	40,133
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	3,770	$176.16	$664,123	46,699
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	2,944	$176.28	$518,959	50,469
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,976	$176.28	$348,323	53,413
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,856	$176.28	$327,170	55,389
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,757	$176.28	$309,719	57,245
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,735	$176.28	$305,841	59,002
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,657	$176.28	$292,091	60,737
2022-03-17	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	1,420	$176.28	$250,313	62,394
2022-03-15	Decker Robert J	Controller, CAO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	5,000	$0.00	$0	8,462
2022-03-15	Decker Robert J	Controller, CAO	Open-market sell S	Common Stock	2,750	$175.51	$482,642	15,473
2022-03-15	Decker Robert J	Controller, CAO	Open-market sell S	Common Stock	2,000	$175.51	$351,012	18,223
2022-03-15	Decker Robert J	Controller, CAO	Open-market sell S	Common Stock	250	$175.51	$43,876	20,223
2022-03-15	Decker Robert J	Controller, CAO	Exercise / conversion M	Common Stock	5,000	$72.54	$362,700	20,473
2022-03-08	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	350	$170.26	$59,588	27,084
2022-02-15	Adamczyk Darius	Dir	Equity grant / award A · derivative	Deferred Share Units	1,030	$0.00	$0	1,030
2022-02-14	Swanson James D.	See Remarks	Equity grant / award A · derivative	Restricted Share Units	1,961	$0.00	$0	1,961
2022-02-14	Swanson James D.	See Remarks	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	19,368	$165.89	$3,212,958	19,368
2022-01-14	Gorsky Alex	Dir	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	231,951	$65.37	$15,162,637	0
2022-01-14	Gorsky Alex	Dir	Other disposed transaction F	Common Stock	150,943	$167.84	$25,334,273	544,658
2022-01-14	Gorsky Alex	Dir	Exercise / conversion M	Common Stock	231,951	$65.37	$15,162,637	695,601
2021-12-09	Gorsky Alex	Dir	Equity grant / award G	Common Stock	6,320	$0.00	$0	463,650
2021-12-07	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	242	$161.67	$39,145	4,114
2021-09-07	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	223	$174.53	$38,908	3,872
2021-07-02	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series G Preferred Stock	48,068,690	$0.00	$0	0
2021-07-02	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series F-2 Preferred Stock	7,587,828	$0.00	$0	0
2021-07-02	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series E-2 Preferred Stock	6,451,188	$0.00	$0	0
2021-07-02	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series D-2 Preferred Stock	4,032,259	$0.00	$0	0
2021-07-02	JOHNSON & JOHNSON	10%	Exercise / conversion C	Common Stock	3,495,575	—	—	3,495,575
2021-06-08	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	226	$165.46	$37,408	3,649
2021-03-09	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	211	$157.66	$33,244	3,423
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Restricted Share Units	3,572	$0.00	$0	0
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Performance Share Units	3,573	$0.00	$0	0
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Other disposed transaction F	Common Stock	1,950	$165.55	$322,822	39,585
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Other disposed transaction F	Common Stock	1,425	$165.55	$235,909	41,535
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	3,572	$0.00	$0	42,960
2021-02-12	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	3,573	$0.00	$0	39,388
2021-02-09	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	1,123	$0.00	$0	24,201
2021-02-08	Wengel Kathryn E	EVP, Chief GSC Officer	Equity grant / award A · derivative	Restricted Share Units	1,971	$0.00	$0	1,971
2021-02-08	Wengel Kathryn E	EVP, Chief GSC Officer	Equity grant / award A · derivative	Performance Share Units	8,704	$0.00	$0	8,704
2021-02-08	Wengel Kathryn E	EVP, Chief GSC Officer	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	43,293	$0.00	$0	43,293
2020-12-09	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	54,662	$0.00	$0	0
2020-12-09	Sneed Michael E	EVP, Global Corp Aff & COO	Open-market sell S	Common Stock	54,662	$152.93	$8,359,460	56,079
2020-12-09	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M	Common Stock	54,662	$62.20	$3,399,976	110,741
2020-12-08	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	214	$149.21	$31,894	2,089
2020-09-08	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	213	$0.00	$0	1,875
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	7,877	$0.00	$0	0
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	8,238	$0.00	$0	0
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	8,238	$153.53	$1,264,755	58,420
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	7,877	$153.51	$1,209,183	66,658
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	7,877	$65.37	$514,919	74,535
2020-09-02	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	8,238	$62.20	$512,404	66,658
2020-07-28	McEvoy Ashley	EVP, WW Chair, Medical Devices	Open-market sell S	Common Stock	29,000	$147.47	$4,276,630	21,682
2020-06-30	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Warrants to purchase Common Shares	89,118	$0.00	$0	89,118
2020-06-30	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Warrants to purchase Class B Preferred Shares	475,802	$0.00	$0	0
2020-06-30	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Class B Preferred Shares	5,059,460	$0.00	$0	0
2020-06-30	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Class A Preferred Shares	10,666,667	$0.00	$0	0
2020-06-30	JOHNSON & JOHNSON	10%	Open-market buy P	Common Shares	725,000	$17.00	$12,325,000	3,670,516
2020-06-30	JOHNSON & JOHNSON	10%	Exercise / conversion C	Common Shares	2,945,516	—	—	2,945,516
2020-06-09	WEINBERGER MARK A	Dir	Equity grant / award A · derivative	Deferred Share Units	214	$0.00	$0	1,662
2020-03-13	PEREZ WILLIAM D	Dir	Open-market buy P	Common Stock	500	$127.69	$63,843	16,030
2020-03-10	HEWSON MARILLYN A	Dir	Equity grant / award A · derivative	Deferred Share Units	227	$0.00	$0	1,448
2020-02-21	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	19,224	$0.00	$0	0
2020-02-21	Mongon Thibaut	Exec VP, WW Chair, Consumer	Open-market sell S	Common Stock	39,224	$147.96	$5,803,583	35,815
2020-02-21	Mongon Thibaut	Exec VP, WW Chair, Consumer	Exercise / conversion M	Common Stock	19,224	$90.44	$1,738,619	75,039
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Restricted Share Units	7,592	$0.00	$0	0
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Performance Share Units	8,217	$0.00	$0	0
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Other disposed transaction F	Common Stock	4,203	$150.46	$632,383	58,420
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Other disposed transaction F	Common Stock	2,909	$150.46	$437,688	62,623
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	7,592	$0.00	$0	65,532
2020-02-13	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	8,217	$0.00	$0	57,940
2020-02-11	PEREZ WILLIAM D	Dir	Equity grant / award A · derivative	Deferred Share Units	1,221	$0.00	$0	26,152
2020-02-11	MULCAHY ANNE M	Dir	Equity grant / award A · derivative	Deferred Share Units	1,221	$0.00	$0	14,591
2020-02-10	Stoffels Paulus	Vice Chair, Exec Committee	Equity grant / award A · derivative	Restricted Share Units	5,241	$0.00	$0	5,241
2020-02-10	Stoffels Paulus	Vice Chair, Exec Committee	Equity grant / award A · derivative	Performance Share Units	27,686	$0.00	$0	27,686
2020-02-10	Stoffels Paulus	Vice Chair, Exec Committee	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	134,064	$0.00	$0	134,064
2020-02-03	McEvoy Ashley	EVP, WW Chair, Medical Devices	Exercise / conversion M · derivative	Restricted Share Units	38,650	$0.00	$0	0
2020-02-03	McEvoy Ashley	EVP, WW Chair, Medical Devices	Other disposed transaction F	Common Stock	15,405	$149.32	$2,300,275	42,749
2020-02-03	McEvoy Ashley	EVP, WW Chair, Medical Devices	Exercise / conversion M	Common Stock	38,650	$0.00	$0	58,154
2020-01-30	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	58,128	$0.00	$0	0
2020-01-30	Sneed Michael E	EVP, Global Corp Aff & COO	Open-market sell S	Common Stock	58,128	$149.39	$8,683,568	49,383
2020-01-30	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M	Common Stock	58,128	$62.62	$3,639,975	107,511
2019-12-13	Joly Hubert	Dir	Open-market buy P	Common Stock	5,000	$141.28	$706,399	5,000
2019-12-12	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	2,017	$0.00	$0	0
2019-12-12	Wengel Kathryn E	EVP, Chief GSC Officer	Open-market sell S	Common Stock	2,017	$141.07	$284,538	49,719
2019-12-12	Wengel Kathryn E	EVP, Chief GSC Officer	Exercise / conversion M	Common Stock	2,017	$62.62	$126,305	51,736
2019-12-10	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	349	$0.00	$0	20,425
2019-09-11	PEREZ WILLIAM D	Dir	Equity grant / award G	Common Stock	2,692	$0.00	$0	15,530
2019-09-10	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	382	$0.00	$0	20,076
2019-06-11	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	350	$0.00	$0	19,693
2019-03-12	Washington A. Eugene	Dir	Equity grant / award A · derivative	Deferred Share Units	341	$0.00	$0	19,344
2019-02-12	Davis Ian	Dir	Equity grant / award A · derivative	Deferred Share Units	1,402	$0.00	$0	13,007
2019-02-11	Kapusta Ronald A	Controller, CAO	Equity grant / award A · derivative	Restricted Share Units	1,414	$0.00	$0	1,414
2019-02-11	Kapusta Ronald A	Controller, CAO	Exercise / conversion M · derivative	Performance Share Units	2,839	$0.00	$0	0
2019-02-11	Kapusta Ronald A	Controller, CAO	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	6,880	$0.00	$0	6,880
2019-02-11	Kapusta Ronald A	Controller, CAO	Other disposed transaction F	Common Stock	940	$131.94	$124,024	17,757
2019-02-11	Kapusta Ronald A	Controller, CAO	Equity grant / award A	Common Stock	466	$0.00	$0	18,697
2019-02-11	Kapusta Ronald A	Controller, CAO	Exercise / conversion M	Common Stock	2,839	$0.00	$0	18,231
2019-02-08	Kapusta Ronald A	Controller, CAO	Exercise / conversion M · derivative	Restricted Share Units	2,484	$0.00	$0	0
2019-02-08	Kapusta Ronald A	Controller, CAO	Other disposed transaction F	Common Stock	733	$132.00	$96,756	15,392
2019-02-08	Kapusta Ronald A	Controller, CAO	Exercise / conversion M	Common Stock	2,484	$0.00	$0	16,125
2018-12-14	MULCAHY ANNE M	Dir	Open-market buy P	Common Stock	748	$133.76	$100,050	6,537
2018-12-13	Kapusta Ronald A	Controller, CAO	Open-market sell S	Common Stock	3,643	$147.31	$536,638	13,641
2018-12-11	WILLIAMS RONALD A	Dir	Equity grant / award A · derivative	Deferred Share Units	350	$0.00	$0	18,959
2018-12-04	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	14,403	$0.00	$0	0
2018-12-04	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	27,160	$0.00	$0	0
2018-12-04	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	41,563	$146.68	$6,096,552	78,327
2018-12-04	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M	Common Stock	14,403	$90.44	$1,302,607	119,890
2018-12-04	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M	Common Stock	27,160	$100.06	$2,717,630	105,487
2018-12-03	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	77,213	$0.00	$0	14,403
2018-12-03	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	47,919	$0.00	$0	27,160
2018-12-03	Fasolo Peter	Exec VP, Chief HR Officer	Open-market sell S	Common Stock	125,132	$146.31	$18,308,689	78,327
2018-12-03	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M	Common Stock	47,919	$100.06	$4,794,775	203,459
2018-12-03	Fasolo Peter	Exec VP, Chief HR Officer	Exercise / conversion M	Common Stock	77,213	$90.44	$6,983,144	155,540
2018-11-23	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	30,943	$0.00	$0	0
2018-11-23	Sneed Michael E	EVP, Global Corp Aff & COO	Open-market sell S	Common Stock	30,943	$142.46	$4,407,985	39,874
2018-11-23	Sneed Michael E	EVP, Global Corp Aff & COO	Exercise / conversion M	Common Stock	30,943	$58.33	$1,804,905	70,817
2018-11-16	Gorsky Alex	Chairman, CEO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	119,770	$0.00	$0	0
2018-11-16	Gorsky Alex	Chairman, CEO	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	144,695	$0.00	$0	0
2018-11-16	Gorsky Alex	Chairman, CEO	Open-market sell S	Common Stock	264,465	$145.96	$38,600,968	336,559
2018-11-16	Gorsky Alex	Chairman, CEO	Exercise / conversion M	Common Stock	119,770	$62.62	$7,499,997	601,024
2018-11-16	Gorsky Alex	Chairman, CEO	Exercise / conversion M	Common Stock	144,695	$62.20	$9,000,029	481,254
2018-11-08	Kapusta Ronald A	Controller, CAO	Open-market sell S	Common Stock	8,441	$145.15	$1,225,200	17,284
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	5,130	$0.00	$0	0
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	15,577	$0.00	$0	84,423
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	19,293	$0.00	$0	0
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Open-market sell S	Common Stock	40,000	$144.36	$5,774,480	93,555
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M	Common Stock	5,130	$58.33	$299,233	133,555
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M	Common Stock	15,577	$65.37	$1,018,268	128,425
2018-11-07	Duato Joaquin	Vice Chair, Exec Committee	Exercise / conversion M	Common Stock	19,293	$62.20	$1,200,025	112,848
2018-09-11	WILLIAMS RONALD A	Dir	Equity grant / award A · derivative	Deferred Share Units	364	$0.00	$0	18,608
2018-09-07	Kapusta Ronald A	Controller, CAO	Open-market sell S	Common Stock	7,899	$137.18	$1,083,607	25,725
2018-08-27	McEvoy Ashley	EVP, WW Chair, Medical Devices	Other disposed transaction I	Common Stock	142	$134.92	$19,159	2,215
2018-07-19	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series A Preferred Stock	2,400,000	$0.00	$0	0
2018-07-19	JOHNSON & JOHNSON	10%	Exercise / conversion C	Common Stock	2,400,000	—	—	2,400,000
2018-06-12	WILLIAMS RONALD A	Dir	Equity grant / award A · derivative	Deferred Share Units	404	$0.00	$0	18,244
2018-05-07	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series F Preferred Stock	248,631	$0.00	$0	0
2018-05-07	JOHNSON & JOHNSON	10%	Exercise / conversion C · derivative	Series E Preferred Stock	1,145,038	$0.00	$0	0
2018-05-07	JOHNSON & JOHNSON	10%	Exercise / conversion C	Common Stock	37,388	—	—	235,251
2018-05-07	JOHNSON & JOHNSON	10%	Exercise / conversion C	Common Stock	197,863	—	—	197,863
2018-03-13	WILLIAMS RONALD A	Dir	Equity grant / award A · derivative	Deferred Share Units	363	$0.00	$0	17,841
2018-02-15	Stoffels Paulus	Exec VP, Chief Scientific Off	Exercise / conversion M · derivative	Employee Stock Options (Right to Buy)	155,342	$0.00	$0	0
2018-02-15	Stoffels Paulus	Exec VP, Chief Scientific Off	Open-market sell S	Common Stock	155,342	$129.86	$20,172,401	202,564
2018-02-15	Stoffels Paulus	Exec VP, Chief Scientific Off	Exercise / conversion M	Common Stock	155,342	$90.44	$14,049,130	357,906
2018-02-13	WILLIAMS RONALD A	Dir	Equity grant / award A · derivative	Deferred Share Units	1,428	$0.00	$0	17,477
2018-02-12	Kapusta Ronald A	Controller, CAO	Equity grant / award A · derivative	Restricted Share Units	2,048	$0.00	$0	2,048
2018-02-12	Kapusta Ronald A	Controller, CAO	Exercise / conversion M · derivative	Performance Share Units	1,801	$0.00	$0	0
2018-02-12	Kapusta Ronald A	Controller, CAO	Equity grant / award A · derivative	Employee Stock Options (Right to Buy)	9,720	$0.00	$0	9,720
2018-02-12	Kapusta Ronald A	Controller, CAO	Other disposed transaction F	Common Stock	697	$129.51	$90,268	33,624
2018-02-12	Kapusta Ronald A	Controller, CAO	Equity grant / award A	Common Stock	649	$0.00	$0	34,321
2018-02-12	Kapusta Ronald A	Controller, CAO	Exercise / conversion M	Common Stock	1,801	$0.00	$0	33,672
2018-02-09	Kapusta Ronald A	Controller, CAO	Exercise / conversion M · derivative	Restricted Share Units	2,702	$0.00	$0	0
2018-02-09	Kapusta Ronald A	Controller, CAO	Other disposed transaction F	Common Stock	795	$128.18	$101,903	31,871
2018-02-09	Kapusta Ronald A	Controller, CAO	Exercise / conversion M	Common Stock	2,702	$0.00	$0	32,666

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count